February, 2009Victims of 2007 Minnesota Bridge Collapse Offered $36.4 Million
People who were injured and relatives of victims killed in the 2007 collapse of a bridge in Minneapolis have been offered a total of $36.4 million in compensation, state officials said. The amount, to be divided up between 179 victims of the tragedy, was offered by the state’s victim compensation fund on Feb. 27, 2009. Individual victims of the collapse have until April 16, 2009 to either accept or reject the compensation, officials said. An attorney for the panel that …
Continue →Continental Airlines Sued By Kin of Woman Killed in Buffalo Air Tragedy
In the first of what could be many such civil suits, relatives of a woman who died along with 48 other people on Continental Airlines Flight 3407 when the commuter plane crashed into a Buffalo suburb in February 2009 have filed a lawsuit against the airline and others.
Continue →Wall Street Earns Poor Grades from Main Street For Honesty and Ethics, New Survey Finds
Don’t trust Wall Street executives? You’re not alone, according to a new survey of public opinion on the honesty and ethics of the nation’s top business executives.
Continue →Obama’s Proposed Budget Includes Billions to Bolster FDA
The embattled U.S. Food and Drug Administration, widely blamed for poor performance in detecting recent deadly outbreaks of salmonella tied to contaminated tomatoes and peanut butter, would get billions more in funding from the federal budget proposed by President Barack Obama. Under Obama’s spending plan for the nation, his first as President, the FDA would get more money, about $1 billion, to help the agency better evaluate the value of less expensive generic drugs and $6 billion to cover increased …
Continue →Seroquel’s Maker ‘Buried’ Findings of Link to Diabetes for Years, Newly Released Court Documents Show
AstraZeneca, the pharmaceutical company behind the popular antipsychotic drug Seroquel, conspired to conceal negative study results showing the drug had caused weight gain and diabetes in some patients, according to newly released company emails and other documents.
Continue →Top Stanford Financial Executive Arrested for Obstructing Federal Investigation
The chief investment officer of Stanford Financial Group, the firm accused of carrying out an $8 billion scheme to defraud thousands of investors, has been arrested on charges she was blocking the government’s investigation into the allegations.
Continue →Certain LG 830 “Spyder” Cell Phones Recalled For Upgrade Due to Dropped Connection or Poor Connection on Emergency 911 Calls
The recalled phones can have difficulty sustaining a connection or have poor voice quality on calls to emergency 911.
Continue →Psoriasis Drug Raptiva Banned in Canada; U.S. and Europe May Follow Suit
Raptiva, the drug used for treatment of the skin condition psoriasis that has been linked to a rare but deadly brain infection, has been banned by Canadian health officials. The move is just the latest in a string of blows for the controversial drug that also is facing increased scrutiny in Europe and the United States. The U.S. Food and Drug Administration recently launched an investigation into a possible link between Raptiva and progressive multifocal leukoencephalopathy (PML). There have been …
Continue →Proposed Drug May Improve Walking Ability for MS Patients
A new drug now being developed may someday help people with multiple sclerosis (MS) walk better, increasing their ability to get around and boosting their overall quality of life, new medical research suggests. The drug, called fampridine, is under development by Acorda Therapeutics, Inc. of Hawthorne, New York. If approved by the Food and Drug Administration, the drug could be the first medication to reverse a common symptom of MS, according to researchers from the University of Rochester Medical Center …
Continue →FDA: Firm Accused of Sending Contaminated Syringes Had Been Warned in 2005
Two years before syringes from a North Carolina medical device maker were linked to an outbreak of bacterial contamination blamed for at least five deaths and hundreds of illnesses, the Food and Drug Administration warned the company about significant safety violations at the plant, officials said. The company, AM2PAT Inc., is accused of skipping sterilization testing of its syringes in 2007 and shipping contaminated needles filled with the blood-thinner Heparin and saline solution used to flush intravenous lines. AM2PAT Inc. …
Continue →Recent Related Features
All Stories
facebook
rss
twitter